TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
16,812
|
15,737
|
5,135 |
Financial expenses |
17
|
0
|
9 |
Earnings before taxes |
-1,215
|
1,556
|
-5,033 |
EBITDA |
-1,136
|
1,594
|
-5,001 |
Total assets |
67,238
|
68,015
|
73,921 |
Current assets |
15,984
|
24,055
|
32,589 |
Current liabilities |
4,560
|
4,807
|
6,855 |
Equity capital |
62,678
|
63,208
|
67,066 |
- share capital |
1,804
|
1,795
|
1,953 |
Employees (average) |
13
|
10
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.2%
|
92.9%
|
90.7% |
Turnover per employee |
1,293
|
1,574
|
571 |
Profit as a percentage of turnover |
-7.2%
|
9.9%
|
-98.0% |
Return on assets (ROA) |
-1.8%
|
2.3%
|
-6.8% |
Current ratio |
350.5%
|
500.4%
|
475.4% |
Return on equity (ROE) |
-1.9%
|
2.5%
|
-7.5% |
Change turnover |
994
|
11,018
|
2,448 |
Change turnover % |
6%
|
233% | |
Chg. No. of employees |
3
|
1
![]() |
1 |
Chg. No. of employees % |
30%
|
11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.